Healthcare provider profile · identity verified

Jacob Daniel Brannen, PA-C

Physician Assistant · ROANOKE, VA · NPI 1629315460

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	540	182
Hydrochlorothiazide	Hydrochlorothiazide	343	123
Lisinopril	Lisinopril	339	117
Amlodipine Besylate	Amlodipine Besylate	338	115
Losartan Potassium	Losartan Potassium	334	128
Rosuvastatin Calcium	Rosuvastatin Calcium	297	104
Omeprazole	Omeprazole	284	99
Simvastatin	Simvastatin	229	73
Levothyroxine Sodium	Levothyroxine Sodium	206	71
Pantoprazole Sodium	Pantoprazole Sodium	191	69
Alprazolam	Alprazolam	167	47
Metformin Hcl	Metformin Hcl	158	54
Metoprolol Tartrate	Metoprolol Tartrate	131	50
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	128	42
Metoprolol Succinate	Metoprolol Succinate	126	48
Furosemide	Furosemide	122	52
Metformin Hcl Er	Metformin Hcl	114	44
Prednisone	Prednisone	114	95
Tamsulosin Hcl	Tamsulosin Hcl	113	41
Pravastatin Sodium	Pravastatin Sodium	110	36
Albuterol Sulfate Hfa	Albuterol Sulfate	109	49
Eliquis	Apixaban	102	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	100	33
Gabapentin	Gabapentin	99	39
Azithromycin	Azithromycin	96	65
Venlafaxine Hcl Er	Venlafaxine Hcl	96	19
Sertraline Hcl	Sertraline Hcl	93	40
Allopurinol	Allopurinol	90	29
Montelukast Sodium	Montelukast Sodium	89	30
Bupropion Xl	Bupropion Hcl	85	19
Fluoxetine Hcl	Fluoxetine Hcl	81	28
Duloxetine Hcl	Duloxetine Hcl	79	24
Atenolol	Atenolol	77	25
Clopidogrel	Clopidogrel Bisulfate	72	26
Escitalopram Oxalate	Escitalopram Oxalate	66	23
Trazodone Hcl	Trazodone Hcl	66	26
Citalopram Hbr	Citalopram Hydrobromide	65	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	21
Jardiance	Empagliflozin	59	18
Tramadol Hcl	Tramadol Hcl	57	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	22
Tizanidine Hcl	Tizanidine Hcl	56	13
Famotidine	Famotidine	55	21
Fluticasone Propionate	Fluticasone Propionate	55	23
Potassium Chloride	Potassium Chloride	55	20
Spironolactone	Spironolactone	54	18
Carvedilol	Carvedilol	53	19
Cephalexin	Cephalexin	53	48
Meloxicam	Meloxicam	52	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	17
Trulicity	Dulaglutide	50	13
Paroxetine Hcl	Paroxetine Hcl	49	14
Diclofenac Sodium	Diclofenac Sodium	46	16
Glipizide Er	Glipizide	45	14
Mirtazapine	Mirtazapine	45	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	44	43
Doxycycline Hyclate	Doxycycline Hyclate	44	39
Amoxicillin	Amoxicillin	43	31
Glimepiride	Glimepiride	43	14
Ozempic	Semaglutide	43	12
Pioglitazone Hcl	Pioglitazone Hcl	43	14
Esomeprazole Magnesium	Esomeprazole Magnesium	41	13
Zolpidem Tartrate	Zolpidem Tartrate	41	18
Ezetimibe	Ezetimibe	38	17
Lorazepam	Lorazepam	38	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	12
Warfarin Sodium	Warfarin Sodium	34	suppressed
Clonazepam	Clonazepam	33	suppressed
Fluconazole	Fluconazole	31	21
Torsemide	Torsemide	30	11
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	11
Verapamil Er	Verapamil Hcl	28	suppressed
Temazepam	Temazepam	27	suppressed
Ramipril	Ramipril	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	19
Baclofen	Baclofen	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Mounjaro	Tirzepatide	24	suppressed
Promethazine Hcl	Promethazine Hcl	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Nystatin	Nystatin	23	12
Synthroid	Levothyroxine Sodium	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Spiriva Handihaler	Tiotropium Bromide	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Ondansetron Odt	Ondansetron	21	16
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Valsartan	Valsartan	20	suppressed
Diazepam	Diazepam	18	suppressed
Finasteride	Finasteride	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	17
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Eplerenone	Eplerenone	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Cefdinir	Cefdinir	13	11
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Butalbital-Acetaminophen	Butalbital/Acetaminophen	12	suppressed
Carbatrol	Carbamazepine	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Estradiol	Estradiol	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	12
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error